CoinInsight360.com logo CoinInsight360.com logo
BitcoinSistemi 2025-04-15 22:48:07

BREAKING: Technology Company Semler Scientific Steps Up to Buy $500 Million Bitcoin (BTC) – Major Development

Medical technology company Semler Scientific has filed for a $500 million mixed shelf offering with the U.S. Securities and Exchange Commission (SEC), announcing that it plans to use the proceeds to potentially purchase more Bitcoin. In a preliminary prospectus filed with the SEC, Semler stated that it “may, from time to time, offer and sell securities in one or more offerings with an aggregate value of up to $500,000,000.” The offering may involve various types of securities, and Semler intends to provide specific terms and conditions in future prospectus supplements. The company also noted that the securities may be sold directly to investors or through agents, underwriters or brokers. Related News: Users' Patience is Running Out on Altcoins that Promised to Buy Back and Burn: Hasn't Delivered What's Expected in Months Semler shares, which trade on the Nasdaq Capital Markets under the ticker SMLR, have experienced significant volatility over the past year. Between Jan. 1, 2024 and April 14, 2025, the shares rose to as high as $74.73 and fell to as low as $21.03, with the most recent closing price being $34.26. The company attributed this price fluctuation to lower Q1 2024 earnings, the adoption of a Bitcoin-focused treasury policy, and market volatility surrounding crypto assets. However, it noted that the stock fluctuations were not due to any material changes in financial condition or operations. Semler Scientific first entered the bitcoin space last year, joining a growing list of public companies allocating institutional funds to the digital asset. *This is not investment advice. Continue Reading: BREAKING: Technology Company Semler Scientific Steps Up to Buy $500 Million Bitcoin (BTC) – Major Development

https://www.digistore24.com/redir/325658/ceobig/
Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.